The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 2:21 AM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #46. Asterias Biotherapeutics, Inc Geron's Embryonic Stem Cell Assets

Acquirer: Asterias Biotherapeutics, Inc (AMEX:BTX)
Acquiree: Geron's Embryonic Stem Cell Assets
Details: Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT:BTX) jointly announced today the closing of the transactions under the Asset Contribution Agreement (the "Agreement") with Geron Corporation, previously announced on January 7, 2013, pursuant to which Asterias Biotherapeutics acquired Geron's human embryonic stem (hES) cell assets, as well as rights to use certain human embryonic stem cell lines, minority stakes in two of BioTime's subsidiaries and stock from BioTime.

Brooklyn ImmunoTherapeutics provides interactive entertainment and technology to its partners in a range of verticals - from bars and restaurants to casinos and senior living centers. Co.'s principal product and service is its interactive entertainment system that provides trivia, card, sports and arcade games through an extended network platform. Generally, as part of the subscription to its platform, Co. provides the equipment for the platform to network subscribers, though Co. has also leased such equipment to certain network subscribers. Co. licenses its content to customers to be installed on equipment they obtain from other parties.

Open the BTX Page at The Online Investor »

Company Name: 
Brooklyn ImmunoTherapeutics Inc
Application Software
Number of ETFs Holding BTX: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the BTX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (3.67 out of 4)
94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 46 of 83 Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.